1Mauch DH, Nagler K, Schumacher S, et al.CNS synaptogenesis promoted by glia - derived cholesterol. Science, 2001, 294:1354- 1357.
2Nathan BP, Bellosta S, Sanan DA, et al.Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science,1994, 264:850 - 852.
3Mahley RW, Rail SC Jr. Apolipoprotein E :far more than a lipid transport protein. Annu Rev Genomics Hum Genet, 2000, 1:507 -537.
4Zannis VI , McPherson J, Goldberger G, et al. Synthesis, intracellular processing, and signal peptide of human apolipoprotein E. J Biol Chem, 1984, 259:5495 - 5499.
5McLean JW, Elshourbagy NA, Chang DJ, et al. Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant. J Biol Chem, 1984, 259:6498 -6504.
6Zannis VI, Breslow JL, Utermann G, et al.Proposed nomenclature of apoE isoproteins,apoE genotypes, and phenotypes. J Lipid Res, 1982, 23:911 -914.
7Farrer LA, Cupples LA, Haines JL, et al.Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer' s disease. A meta - analysis.APOE and Alzheimer' s Disease Meta Analysis Consortium. JAMA, 1997, 278 : 1349 -1356.
8Mahley RW, Huang Y. Apolipoprotein E:from atheroscierosis to Alzheimer' s disease and beyond. Curr Opin Lipidol, 1999, 10:207 -217.
9Poirer J. Apolipoprotein E in animal models of CNS injury and in Alzheimer' s disease.Trends Neurosci, 1994, 17:525 -530.
10McCarron MO, Dclong D, Alberts MJ.APOE genotype as a risk factor for ischemic cerebrovascular disease : a meta - analysis. Neurology, 1999, 53:1308 - 1311.
